References
- Frith P, Gray R, MacLennan S, Ambler P. The Eye in Clinical Practice. 2nd ed. Malden, MA: Blackwell Science, 2001.
- Kaufman HE, Rayfield MA, Gebhardt BM. Herpes simplex viral infections. In: Kaufman HE, Barron BA, McDonald MB, eds. The Cornea. 2nd ed. Boston: Butterworth-Heinemann, 1998:247–277.
- Ruyechan WT, Morse LS, Knipe DM, Roizman B. Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells. J Virol. 1979;29:677–697.
- Centifanto-Fitzgerald YM, Yamaguchi T, Kaufman HE, Tognon M, Roizman B. Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA. J Exp Med. 1982;155:475–489.
- Kaufman HE, Varnell ED, Centifanto YM, Kissling GE. Effect of the herpes simplex virus genome on the response of infection to corticosteroids. Am J Ophthalmol. 1985; 100:114–118.
- Kaufman HE, Varnell ED, Thompson 11W. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol. 1999;127:531–536.
- Kaufman HE, Varnell ED, Toshida H, Kanai A, Thompson HW, Bazan NG. Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. Am J Ophthalmol. 2001;131:643–646.
- Cook SD, Paveloff MJ, Doucet JJ, Cottingham AJ, Sedarati F, Hill TM. Ocular herpes simplex virus reactivation in mice latently infected with latency-associated transcript mutants. Invest Ophthalmol Vis Sci. 1991;32:1558–1561.
- Haruta Y, Rootman DS, Xie L, Kiritoshi A, Hill TM. Recurrent HSV-1 corneal lesions in rabbits induced by cyclophosphamide and dexamethasone. Invest Ophthalmol Vis Sci. 1989;30: 371–376.
- Hill JM, Rayfield MA, Haruta Y. Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits. Curr Eye Res. 1987;6: 91–97.
- Hill JIM, Wen R, Halford WP Pathogenesis and molecular biology of ocular HSV in the rabbit. In: Brown MS, MacLean, eds. Herpes Simplex Virus Protocols. Totowa: Humana Press/Wiley, 1998;291–315.
- Kwon BS, Gangarosa LP, Burch KD, deBack J, Hill JIM. Induction of ocular herpes simplex virus shedding by iontophoresis of epinephrine into rabbit cornea. Invest Ophthalmol Vis Sci. 1981;21:442–449.
- Loutsch JIM, Sainz B Jr, Marquart ME, Zheng X, Kesavan P, Higaki S, Hill JM, Tal-Singer R. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establish-ment of latency in rabbits. Antimicrob Agents Chemother. 2001;45: 2044–2053.
- Chen X-P, Mata M, Kelley M, Glorioso JC, Fink DJ. The relationship of herpes simplex virus latency associated transcript expression to genome copy number: A quantita-tive study using laser capture microdissection. J Neuro Virol. 2002;8:204–210.
- Cohrs RJ, Randall J, Smith J, Gilden DH, Dabrowski C, van der Keyl H, Tal-Singer R. Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR. J Virol. 2000;74 :11464–11471.
- Pevenstein SR, Williams RK, McChesney D, Mont EK, Smialek JE, Straus SE. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J Virol. 1999;73:10514–10518.
- Halford WP, Schaffer PA. Optimized viral dose and tran-sient immunosuppression enable herpes simplex virus ICPO-null mutants to establish wild-type levels of latency in vivo. J Virol. 2000;74:5957–5967.
- Halford WP, Schaffer PA. ICPO is required for efficient reactivation of herpes simplex virus type 1 from neuronal latency. J Virol. 2001;7 5:3240–3249.
- Hardwicke MA, Schaffer PA. Differential effects of nerve growth factor and dexamethasone on herpes simplex virus type 1 oriL- and oriS-dependent DNA replication in PC12 cells. J Virol. 1997;71:3580–3587.
- Higaki S, Gebhardt BM, Lukiw WJ, Thompson HW, Hill JIM. Effect of immunosuppression on gene expression in the HSV-1 latently infected mouse trigeminal ganglion. Invest Ophthalmol Vis Sci. 2002;43: 1862–1869.